Latest portfolio news

BC Platforms and NTT Group announce exclusive collaboration

New Genialis RNA biomarker accurately predicts KRAS outcomes in lung cancer patients

Nucleai and GoPath Diagnostics announce strategic collaboration

Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment

Carevive partners with Canopy Cancer Collective

Mika selected for White House initiative

Iktos and Elsevier announce their partnership

Concr secures Innovate UK funding to advance cancer precision therapy

VeriSIM Life Predicting Translatable Drug Combinations for ADCs – A Pharma Partner Case Study